A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails

NCT07382427 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis of Toenail

Interventions

DRUG: 2.4% Topical Terbinafine
DRUG: 10% Topical Efinaconazole
OTHER: Vehicle Control

Sponsor

Onyx Axiom